Clinical trial
Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of…
NCT00003780 · Meyer Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00003780 |
|---|---|
| Title | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas |
| Official title | An Open Label Randomized Trial Comparing the Safety and Efficacy of Systemic Chemotherapy (Gemcitabine) to Immunotherapy (CYTOIMPLANT - Intra Tumor Implants of Allogeneic Peripheral Blood Mononuclear Cells Sensitized Against Patient Alloantigens by Mixed Lymphocyte Culture) as First Line Therapy for… |
| Lead sponsor | Meyer Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | tumor infiltrating lymphocyte therapy, gemcitabine hydrochloride |
| Enrollment | 150 |
| Start date | Dec 1, 1998 |
| First posted | Sep 14, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: